Concurrent Rho-Kinase and Tyrosine Kinase Platelet-Derived Growth Factor Inhibition in Experimental Pulmonary Hypertension

Publisher： Karger

E-ISSN： 1423-0313|93|3-4|145-150

ISSN： 0031-7012

Source： Pharmacology, Vol.93, Iss.3-4, 2014-03, pp. : 145-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells

By Kang Minyong   Lee Kyoung-Hwa   Lee Hye Sun   Jeong Chang Wook   Kwak Cheol   Kim Hyeon Hoe   Ku Ja Hyeon  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 321-321

MDPI

Access to resources Recommend Favorite

Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

By Jiang Chunguo   Huang Hui   Liu Jia   Wang Yanxun   Lu Zhiwei   Xu Zuojun  

International Journal of Molecular Sciences, Vol. 13, Iss. 7, 2012-07 ,pp. : 8293-8307

MDPI

Access to resources Recommend Favorite

Protective Effect of Resveratrol on Agonist-Dependent Regulation of Vascular Contractility via Inhibition of Rho-Kinase Activity

By  

Pharmacology, Vol. 86, Iss. 1, 2010-06 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Inhibition of Rho-Kinase by Hydroxyfasudil Prevents Vasopressin-Induced Myocardial Ischemia in Donryu Rats by Attenuating Coronary Vasoconstriction

By  

Pharmacology, Vol. 75, Iss. 3, 2005-10 ,pp. : 145-151

Karger

Access to resources Recommend Favorite

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

By Chang Shih-Chieh   Chang Cheng-Yu   Shih Jin-Yuan  

Cancers, Vol. 3, Iss. 2, 2011-06 ,pp. : 2667-2678

MDPI

Access to resources Recommend Favorite